Ambeed.cn

首页 / / / PDHK / AZD7545

AZD7545 {[allProObj[0].p_purity_real_show]}

货号:A349552

AZD7545是一种选择性PDHK2(丙酮酸脱氢酶激酶2)抑制剂,对PDHK1和PDHK2的IC50分别为36.8 nM和6.4 nM。

AZD7545 化学结构 CAS号:252017-04-2
AZD7545 化学结构
CAS号:252017-04-2
AZD7545 3D分子结构
CAS号:252017-04-2
AZD7545 化学结构 CAS号:252017-04-2
AZD7545 3D分子结构 CAS号:252017-04-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

AZD7545 纯度/质量文件 产品仅供科研

货号:A349552 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

AZD7545 生物活性

描述 PDHK (pyruvate dehydrogenase kinase) is a kinase enzyme which acts to inactivate the enzyme pyruvate dehydrogenase by phosphorylating it using ATP. AZD7545 is a novel PDHK inhibitor with IC50 values of 36.8nM/6.4nM for PDHK1/2[3], and EC50 value of 5.2nM for increasing PDH activity. It stimulated the rate of pyruvate oxidation with EC50 value of 105nM in rat hepatocytes. A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%. A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa/fa) rats. AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose[4]. AZD7545 failed to inhibit PDHK4 and paradoxically, at higher concentrations (>10 nM), AZD7545 stimulated PDHK4 activity[3].
作用机制 AZD7545 docks into the lipoamide-binding site on PDHK2 thus inhibiting interaction with the E2 subunit. It inhibits PDHK in a non-ATP competitive manner.[3]

AZD7545 细胞实验

Cell Line
Concentration Treated Time Description References
SKMel30 10 μM 120 h Inhibition of PDK1 leads to growth suppression of NRAS mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
501Mel 10 μM 90 h Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
IGR37 10 μM 90 h Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
A375 10 μM 90 h Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
PDK3 50 nM 30 min Determination of IC50 for AZD7545 on PDK3, resulting in 600 nM Structure. 2007 Aug;15(8):992-1004.
PDK1 50 nM 30 min Determination of IC50 for AZD7545 on PDK1, resulting in 87 nM Structure. 2007 Aug;15(8):992-1004.
MelJuso 10 μM 120 h Inhibition of PDK1 leads to growth suppression of NRAS mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
IPC298 10 μM 120 h Inhibition of PDK1 leads to growth suppression of NRAS mutant cells Mol Cancer. 2017 Jun 8;16(1):102.
SK-MEL-2 >100 μM 96 h AZD7545 did not significantly inhibit proliferation in SK-MEL-2 cells, IC50 >100 μM Int J Mol Sci. 2022 Mar 29;23(7):3745.
SK-MEL-28 >100 μM 96 h AZD7545 did not significantly inhibit proliferation in SK-MEL-28 cells, IC50 >100 μM Int J Mol Sci. 2022 Mar 29;23(7):3745.
MeWo 89.3 ±5.0 μM 96 h AZD7545 inhibited proliferation in MeWo cells with an IC50 of 89.3 ±5.0 μM Int J Mol Sci. 2022 Mar 29;23(7):3745.
A375 35.0 ±4.1 μM 96 h AZD7545 inhibited proliferation in A375 cells with an IC50 of 35.0 ±4.1 μM Int J Mol Sci. 2022 Mar 29;23(7):3745.

AZD7545 动物研究

Dose Rat: 10 mg/kg - 30 mg/kg[2] (p.o.), 300 mg/kg[3] (p.o.)
Administration p.o.

AZD7545 参考文献

[1]Morrell JA, Orme J, et al. AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. Biochem Soc Trans. 2003 Dec;31(Pt 6):1168-70.

[2]Mayers RM, Butlin RJ, et al. AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats. Biochem Soc Trans. 2003 Dec;31(Pt 6):1165-7.

[3]Morrell JA, Orme J, Butlin RJ, Roche TE, Mayers RM, Kilgour E. AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. Biochem Soc Trans. 2003 Dec;31(Pt 6):1168-70. doi: 10.1042/bst0311168. PMID: 14641019.

[4]Mayers RM, Butlin RJ, Kilgour E, Leighton B, Martin D, Myatt J, Orme JP, Holloway BR. AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats. Biochem Soc Trans. 2003 Dec;31(Pt 6):1165-7. doi: 10.1042/bst0311165. PMID: 14641018.

AZD7545 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.09mL

0.42mL

0.21mL

10.44mL

2.09mL

1.04mL

20.88mL

4.18mL

2.09mL

AZD7545 技术信息

CAS号252017-04-2
分子式C19H18ClF3N2O5S
分子量 478.87
SMILES Code O=C(N(C)C)C1=CC=C(S(=O)(C2=CC=C(NC([C@@](C)(O)C(F)(F)F)=O)C(Cl)=C2)=O)C=C1
MDL No. MFCD25976792
别名
运输蓝冰
InChI Key DTDZLJHKVNTQGZ-GOSISDBHSA-N
Pubchem ID 16741245
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 45 mg/mL(93.97 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。